| 查看: 3819 | 回复: 7 | ||||
[求助]
求牛人帮忙写一段COVER LETTER里面的一段话，谢谢！
|
|
我想投ACS里面的Chemistry of materials 这个杂志，但在写COVER LETTER 的时候，要写一段关于这个杂志的基本情况，还有就是自己的文章非常符合该杂志之类的话，自己的写作有限，所以请各位牛人帮帮忙，谢谢！ 如果有投过该杂志的可不可以发一下COVER LETTER的模板。 关于该杂志的基本情况，我想从这些方面去写，比如说该杂志致力于研究新型的材料，包括高分子、半导体、纳米复合材料等，要求创新性较高，分析全面深入等，是一篇材料类顶级杂志之类的夸奖杂志的话，最后就是我这篇文章非常符合该杂志之类的。。。请牛人帮写一下英文，谢谢 |
回复此楼» 收录本帖的淘帖专辑推荐
 SCI写作、投稿、经验 | asdf |
» 猜你喜欢
博士读完未来一定会好吗
已经有21人回复
-
导师想让我从独立一作变成了共一第一
已经有5人回复
-
到新单位后，换了新的研究方向，没有团队，持续积累2区以上论文，能申请到面上吗
已经有11人回复
-
读博
已经有4人回复
-
JMPT 期刊投稿流程
已经有4人回复
-
心脉受损
已经有5人回复
-
Springer期刊投稿求助
已经有4人回复
-
小论文投稿
已经有3人回复
-
Bioresource Technology期刊，第一次返修的时候被退回好几次了
已经有9人回复
-
申请2026年博士
已经有6人回复
» 本主题相关商家推荐: (我也要在这里推广)
» 本主题相关价值贴推荐，对您同样有帮助:
紧急求助:ACS上的文章被拒后,请问cover letter此时该如何写?谢谢
已经有13人回复- Advanced Functional Materials投稿需不需要写推荐投稿人？写在cover letter中吗？
已经有14人回复
- word里写的cover letter 贴到email里格式发生变化如何办？
已经有7人回复
- 重投，将原来的意见及改动的地方写在Cover letter里，格式该怎么写？
已经有3人回复
- 给国外期刊投稿一定要写cover letter吗？
已经有10人回复
- Nature投稿cover letter 的一些问题，谢谢大家帮忙
已经有8人回复
- 1.【求助】弱问：cover letter 和 resume的区别是什么？（续）2.赠金币，求祝福
已经有35人回复
- 求各位牛人帮我翻译一段话
已经有1人回复
- cover letter中关于文章字数怎么写
已经有4人回复
- 结束谢谢
已经有6人回复
- 求助修改稿的cover letter怎么写？
已经有13人回复
他乡客
至尊木虫 (知名作家)
- 应助: 1887 (讲师)
- 金币: 14731.7
- 散金: 70
- 红花: 41
- 帖子: 6254
- 在线: 384.4小时
- 虫号: 1575919
- 注册: 2012-01-13
- 性别: GG
- 专业: 有机合成
2楼2012-04-19 11:56:54
mpcctv
荣誉版主 (知名作家)
Peter
- 应助: 1650 (讲师)
- 贵宾: 1.314
- 金币: 9743.6
- 散金: 5975
- 红花: 43
- 沙发: 111
- 帖子: 6607
- 在线: 720.7小时
- 虫号: 736508
- 注册: 2009-03-31
- 性别: GG
- 专业: 理论和计算化学
- 管辖: 签证指南
3楼2012-04-19 12:09:26
4楼2012-04-19 12:36:55
paperhunter
荣誉版主 (文学泰斗)
还没想好
-
专家经验: +14 - SEPI: 1
- 应助: 14603 (教授)
- 贵宾: 11.659
- 金币: 345462
- 散金: 9262
- 红花: 1423
- 沙发: 2016
- 帖子: 127553
- 在线: 8880.4小时
- 虫号: 971012
- 注册: 2010-03-14
- 专业: 环境工程
- 管辖: 论文投稿
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与，应助指数 +1
asheller: 金币+30, ★★★很有帮助, 非常感谢 2012-04-19 14:10:47
感谢参与，应助指数 +1
asheller: 金币+30, ★★★很有帮助, 非常感谢 2012-04-19 14:10:47
|
给楼主提供几个cover letter模板，仅供参考（http://muchong.com/bbs/viewthread.php?tid=2083980 http://muchong.com/bbs/viewthread.php?tid=191002） Dear Editors: We would like to submit the enclosed manuscript entitled “Paper Title”, which we wish to be considered for publication in “Journal Name”. No conflict of interest exits in the submission of this manuscript, and manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed. In this work, we evaluated …… (简要介绍一下论文的创新性). I hope this paper is suitable for “Journal Name”. We deeply appreciate your consideration of our manuscript, and if you have any queries, please don’t hesitate to contact me at the address below. Thank you. Yours sincerely, ×××××× Corresponding author: Name: ××× E-mail: ××××@×××× Dear Editor, We would like to submit the enclosed manuscript entitled "GDNF Acutely Modulates Neuronal Excitability and A-type Potassium Channels in Midbrain Dopaminergic Neurons", which we wish to be considered for publication in Nature Neuroscience. GDNF has long been thought to be a potent neurotrophic factor for the survival of midbrain dopaminergic neurons, which are degenerated in Parkinson’s disease. In this paper, we report an unexpected, acute effect of GDNF on A-type potassium channels, leading to a potentiation of neuronal excitability, in the dopaminergic neurons in culture as well as in adult brain slices. Further, we show that GDNF regulates the K+ channels through a mechanism that involves activation of MAP kinase. Thus, this study has revealed, for the first time, an acute modulation of ion channels by GDNF. Our findings challenge the classic view of GDNF as a long-term survival factor for midbrain dopaminergic neurons, and suggest that the normal function of GDNF is to regulate neuronal excitability, and consequently dopamine release. These results may also have implications in the treatment of Parkinson’s disease. Due to a direct competition and conflict of interest, we request that Drs. XXX of Harvard Univ., and YY of Yale Univ. not be considered as reviewers. With thanks for your consideration, I am Sincerely yours, Dear Editor, We would like to submit the enclosed manuscript entitled "Ca2+-binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release", which we wish to be considered for publication in Neuron. We believe that two aspects of this manuscript will make it interesting to general readers of Neuron. First, we report that GDNF has a long-term regulatory effect on neurotransmitter release at the neuromuscular synapses. This provides the first physiological evidence for a role of this new family of neurotrophic factors in functional synaptic transmission. Second, we show that the GDNF effect is mediated by enhancing the expression of the Ca2+-binding protein frequenin. Further, GDNF and frequenin facilitate synaptic transmission by enhancing Ca2+ channel activity, leading to an enhancement of Ca2+ influx. Thus, this study has identified, for the first time, a molecular target that mediates the long-term, synaptic action of a neurotrophic factor. Our findings may also have general implications in the cell biology of neurotransmitter release. |
5楼2012-04-19 12:52:51
6楼2012-04-19 19:26:18
monkey514
至尊木虫 (知名作家)
多重人格的虫子
- 应助: 49 (小学生)
- 金币: 26384.4
- 散金: 669
- 红花: 6
- 沙发: 1
- 帖子: 5325
- 在线: 526.8小时
- 虫号: 876775
- 注册: 2009-10-18
- 专业: 合成药物化学
【答案】应助回帖
★ ★ ★ ★ ★
感谢参与，应助指数 +1
asheller: 金币+5, ★★★很有帮助 2012-06-05 10:19:01
感谢参与，应助指数 +1
asheller: 金币+5, ★★★很有帮助 2012-06-05 10:19:01
|
Dear editor, We are submitting a manuscript which is intended to be published in *****. This manuscript reported ******. The procedure established in this manuscript is ******. Therefore, we think our manuscript satisfy the essential criteria of *****. We hope you give favorable consideration to this manuscript and look forward to receiving comments from the referees. Please let us know if we can be of any further assistance. Sincerely yours, |
7楼2012-04-19 19:55:14
8楼2012-08-15 15:07:25